Intracellular application of TNF-alpha impairs cell to cell communication via gap junctions in glioma cells

Journal of Neuro-Oncology

Volumn 86, Issue 2, 2008, Pages 143-152

  Haghikia, Aiden ^a   Ladage, Kerstin ^b   Lafênetre, Pauline ^b   Haghikia, Arash ^b   Hinkerohe, Daniel ^c   Smikalla, Dirk ^b   Haase, Claus G ^b   Dermietzel, Rolf ^b   Faustmann, Pedro M ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cx43; GJIC; Glioma cells; Intracellularly applied TNF ; Primary astrocytes; TNFR1

Indexed keywords

COMPLEMENTARY DNA; CONNEXIN 43; GAP JUNCTION PROTEIN; RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL CELL; ARTICLE; ASTROCYTE; CANCER CELL CULTURE; CELL COMMUNICATION; CONTROLLED STUDY; GAP JUNCTION; GLIOMA; GLIOMA CELL; IMMUNOCYTOCHEMISTRY; INHIBITION KINETICS; MEMBRANE STEADY POTENTIAL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; BRAIN NEOPLASMS; CELL COMMUNICATION; CONNEXIN 43; GAP JUNCTIONS; GLIOMA; HUMANS; INTRACELLULAR FLUID; RATS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37249021380     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9462-8     Document Type: Article

References (56)

1. Kallio M, Sankila R, Jaaskelainen J, Karjalainen S, Hakulinen T (1991) A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984. Cancer 68:1394-1400
2. Buckner JC, Ballman KV, Michalak JC, Burton GV, Cascino TL, Schomberg PJ, Hawkins RB, Scheithauer BW, Sandler HM, Marks RS, O'Fallon JR (2006) Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials. J Clin Oncol 24:3871-3879
3. Keles GE, Berger MS (2004) Advances in neurosurgical technique in the current management of brain tumors. Semin Oncol 31:659-665
4. Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479-489
5. Tabernero A, Medina JM, Giaume C (2006) Glucose metabolism and proliferation in glia: Role of astrocytic gap junctions. J Neurochem 99(4):1049-1061
6. Shinoura N, Chen L, Wani MA, Kim YG, Larson JJ, Warnick RE, Simon M, Menon AG, Bi WL, Stambrook PJ (1996) Protein and messenger RNA expression of connexin43 in astrocytomas: Implications in brain tumor gene therapy. J Neurosurg 84:839-845; discussion 846
7. Zhang W, Couldwell WT, Simard MF, Song H, Lin JH, Nedergaard M (1999) Direct gap junction communication between malignant glioma cells and astrocytes. Cancer Res 59:1994-2003
8. Lin JH, Takano T, Cotrina ML, Arcuino G, Kang J, Liu S, Gao Q, Jiang L, Li F, Lichtenberg-Frate H, Haubrich S, Willecke K, Goldman SA, Nedergaard M (2002) Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci 22:4302-4311
9. Nicholson B, Dermietzel R, Teplow D, Traub O, Willecke K, Revel JP (1987) Two homologous protein components of hepatic gap junctions. Nature 329:732-734
10. Dermietzel R, Hertberg EL, Kessler JA, Spray DC (1991) Gap junctions between cultured astrocytes: Immunocytochemical, molecular, and electrophysiological analysis. J Neurosci 11:1421-1432
11. Zhu D, Caveney S, Kidder GM, Naus CC (1991) Transfection of C6 glioma cells with connexin 43 cDNA: Analysis of expression, intercellular coupling, and cell proliferation. Proc Natl Acad Sci USA 88:1883-1887
12. Giaume C, Venance L (1998) Intercellular calcium signaling and gap junctional communication in astrocytes. Glia 24:50-64
13. John GR, Scemes E, Suadicani SO, Liu JS, Charles PC, Lee SC, Spray DC, Brosnan CF (1999) IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc Natl Acad Sci USA 96:11613-11618
14. Faustmann PM, Haase CG, Romberg S, Hinkerohe D, Szlachta D, Smikalla D, Krause D, Dermietzel R (2003) Microglia activation influences dye coupling and Cx43 expression of the astrocytic network. Glia 42:101-108
15. Hinkerohe D, Smikalla D, Haghikia A, Heupel K, Haase CG, Dermietzel R, Faustmann PM (2005) Effects of cytokines on microglial phenotypes and astroglial coupling in an inflammatory coculture model. Glia 52:85-97
16. Chen G, Goeddel DV (2002) TNF-R1 signaling: A beautiful pathway. Science 296:1634-1635
17. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127-3131
18. Jacobsen FW, Rothe M, Rusten L, Goeddel DV, Smeland EB, Veiby OP, Slordal L, Jacobsen SE (1994) Role of the 75-kDa tumor necrosis factor receptor: Inhibition of early hematopoiesis. Proc Natl Acad Sci USA 91:10695-10699
19. Thoma B, Grell M, Pfizenmaier K, Scheurich P (1990) Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J Exp Med 172:1019-1023
20. Hayakawa Y, Smyth MJ (2006) Innate immune recognition and suppression of tumors. Adv Cancer Res 95:293-322
21. Ko L, Koestner A, Wechsler W (1980) Characterization of cell cycle and biological parameters of transplantable glioma cell lines and clones. Acta Neuropathol (Berl) 51:107-111
22. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
23. Laird DW, Puranam KL, Revel JP (1991) Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem J 273(Pt 1):67-72
24. Koller H, Allert N, Oel D, Stoll G, Siebler M (1998) TNF alpha induces a protein kinase C-dependent reduction in astroglial K+ conductance. Neuroreport 9:1375-1378
25. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A (1994) Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94:954-964
26. Chen TC, Hinton DR, Sippy BD, Hofman FM (1997) Soluble TNF-alpha receptors are constitutively shed and downregulate adhesion molecule expression in malignant gliomas. J Neuropathol Exp Neurol 56:541-550
27. Hao C, Beguinot F, Condorelli G, Trencia A, Van Meir EG, Yong VW, Parney IF, Roa WH, Petruk KC (2001) Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res 61:1162-1170
28. Chambaut-Guerin AM, Rouher C, Gauthereau X (1997) p55 tumour necrosis factor receptors distribution in neuroblastoma cells. Neuroreport 8:1451-1456
29. Jones SJ, Ledgerwood EC, Prins JB, Galbraith J, Johnson DR, Pober JS, Bradley JR (1999) TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. J Immunol 162:1042-1048
30. Gaeta ML, Johnson DR, Kluger MS, Pober JS (2000) The death domain of tumor necrosis factor receptor 1 is necessary but not sufficient for Golgi retention of the receptor and mediates receptor desensitization. Lab Invest 80:1185-1194
31. Storey H, Stewart A, Vandenabeele P, Luzio JP (2002) The p55 tumour necrosis factor receptor TNFR1 contains a trans-Golgi network localization signal in the C-terminal region of its cytoplasmic tail. Biochem J 366:15-22
32. Fernandez-Cobo M, Gingalewski C, Drujan D, De Maio A (1999) Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. Cytokine 11:216-224
33. Zucali JR, Morse C, Dinarello CA (1990) The role of protein kinase C in interleukin 1 and tumor necrosis factor alpha induction of fibroblasts to produce and release granulocyte-macrophage colony-stimulating activity. Exp Hematol 18:888-892
34. Schutze S, Machleidt T, Kronke M (1992) Mechanisms of tumor necrosis factor action. Semin Oncol 19:16-24
35. Norris JG, Tang LP, Sparacio SM, Benveniste EN (1994) Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J Immunol 152:841-850
36. Sippy BD, Hofman FM, Wright AD, Wang JL, Gopalakrishna R, Gundimeda U, He S, Ryan SJ, Hinton DR (1996) Induction of intercellular adhesion molecule-1 by tumor necrosis factor-alpha through the 55-kDa receptor is dependent on protein kinase C in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 37:597-606
37. Muller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K (1995) PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. Embo J 14:1961-1969
38. Rahman A, Anwar KN, Malik AB (2000) Protein kinase C-zeta mediates TNF-alpha-induced ICAM-1 gene transcription in endothelial cells. Am J Physiol Cell Physiol 279:C906-C914
39. Esteve PO, Chicoine E, Robledo O, Aoudjit F, Descoteaux A, Potworowski EF, St-Pierre Y (2002) Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B. J Biol Chem 277:35150-35155
40. Lampe PD, TenBroek EM, Burt JM, Kurata WE, Johnson RG, Lau AF (2000) Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J Cell Biol 149:1503-1512
41. Cruciani V, Husoy T, Mikalsen SO (2001) Pharmacological evidence for system-dependent involvement of protein kinase C isoenzymes in phorbol ester-suppressed gap junctional communication. Exp Cell Res 268:150-161
42. Shah MM, Martinez AM, Fletcher WH (2002) The connexin43 gap junction protein is phosphorylated by protein kinase A and protein kinase C: in vivo and in vitro studies. Mol Cell Biochem 238:57-68
43. Cottrell GT, Lin R, Warn-Cramer BJ, Lau AF, Burt JM (2003) Mechanism of v-Src- and mitogen-activated protein kinase-induced reduction of gap junction communication. Am J Physiol Cell Physiol 284:C511-C520
44. Bao X, Reuss L, Altenberg GA (2004) Regulation of purified and reconstituted connexin 43 hemichannels by protein kinase C-mediated phosphorylation of Serine 368. J Biol Chem 279:20058-20066
45. Girao H, Pereira P (2003) Phosphorylation of connexin 43 acts as a stimuli for proteasome-dependent degradation of the protein in lens epithelial cells. Mol Vis 9:24-30
46. Prados MD, Levin V (2000) Biology and treatment of malignant glioma. Semin Oncol 27:1-10
47. Moolten FL (1986) Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res 46:5276-5281
48. Ram Z, Culver KW, Oshiro EM, Viola JJ, DeVroom HL, Otto E, Long Z, Chiang Y, McGarrity GJ, Muul LM, Katz D, Blaese RM, Oldfield EH (1997) Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 3:1354-1361
49. Shand N, Weber F, Mariani L, Bernstein M, Gianella-Borradori A, Long Z, Sorensen AG, Barbier N (1999) A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. Hum Gene Ther 10:2325-2335
50. Prados MD, McDermott M, Chang SM, Wilson CB, Fick J, Culver KW, Van Gilder J, Keles GE, Spence A, Berger M (2003) Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: A phase I/II multi-institutional trial. J Neurooncol 65:269-278
51. Niranjan A, Wolfe D, Fellows W, Goins WF, Glorioso JC, Kondziolka D, Lunsford LD (2004) Gene transfer to glial tumors using herpes simplex virus. Methods Mol Biol 246:323-337
52. Yamamoto M, Fukushima T, Ueno Y, Hayashi S, Kimura H, Soma G, Tomonaga M (2000) Clinical significance of the expression of endothelial-monocyte activating polypeptide II (EMAPII) in the treatment of glioblastoma with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2). Anticancer Res 20:4081-4086
53. Kiwit JC, Schmitz KH, Daum L, Reifenberger G, Roosen N (1991) Effects of recombinant human tumor necrosis factor on rodent gliomas and normal brain. J Neurosurg 75:597-603
54. Duan L, Aoyagi M, Tamaki M, Yoshino Y, Morimoto T, Wakimoto H, Nagasaka Y, Hirakawa K, Ohno K, Yamamoto K (2004) Impairment of both apoptotic and cytoprotective signalings in glioma cells resistant to the combined use of cisplatin and tumor necrosis factor alpha. Clin Cancer Res 10:234-243
55. Baher AG, Andres ML, Folz-Holbeck J, Cao JD, Gridley DS (1999) A model using radiation and plasmid-mediated tumor necrosis factor-alpha gene therapy for treatment of glioblastomas. Anticancer Res 19:2917-2924
56. Niranjan A, Moriuchi S, Lunsford LD, Kondziolka D, Flickinger JC, Fellows W, Rajendiran S, Tamura M, Cohen JB, Glorioso JC (2000) Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration. Mol Ther 2:114-120